Cargando…
Corrigendum to “The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors” [Pharmacol. Res. 147 (2019) 104392]
Autores principales: | Bechman, Katie, Yates, Mark, Galloway, James B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181163/ https://www.ncbi.nlm.nih.gov/pubmed/32014340 http://dx.doi.org/10.1016/j.phrs.2020.104634 |
Ejemplares similares
-
The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors
por: Bechman, Katie, et al.
Publicado: (2019) -
Corrigendum to “Traditional Chinese medicine for COVID-19 treatment” [Pharmacol. Res. 155 (2020) 104743]
por: Ren, Jun-ling, et al.
Publicado: (2020) -
Corrigendum to: Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics Register
por: Bechman, Katie, et al.
Publicado: (2020) -
Corrigendum to “Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost” [Biochem. Pharmacol. 178 (2020) 114057]
por: Mohammed El Tabaa, Manar, et al.
Publicado: (2020) -
Corrigendum to “Novel dynamic fuzzy Decision-Making framework for COVID-19 vaccine dose recipients” [J. Adv. Res. 37 (2022) 147–168]
por: Albahri, O.S., et al.
Publicado: (2023)